Regulatory News
Monday, May 16, 2016
BRIEF-Bone Therapeutics announces further positive efficacy in ALLOB trial
* Announces further positive efficacy in ALLOB Phase I/IIA
delayed-union fracture trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment